
Annual IFRUE Meeting
August 14 to August 17, 2025
Sheraton Downtown Denver Hotel
1550 Court Pl, Denver, CO 80202
Deadline: July 1, 2025
Video Abstract Guidelines
- The recommended abstract length is 250 words or less, excluding the title and authors’ names.
- Abstract title should be descriptive (200 characters or less). Tables and figures are not allowed.
- The primary/submitting author will receive an email confirming receipt of the abstract. Please notify your co-authors that the confirmation was received.
Procedures and Deadlines
- All abstracts must be received by Tuesday, July 1, 2025. Abstracts are approved for presentation and inclusion in the annual scientific program at the recommendation of the 2025 Program Committee.
- Disclosures for ALL authors/co-authors are required within the submission form and their institutions, city, state, country, etc.
- Do not include tables or figures in your abstract.
- Please note only the authors’ and institutions’ names in the specified fields within the abstract form.
- Complete speaker and paper presentation instructions will be provided upon notification of a paper’s acceptance.
Video Guidelines
- There must be only one subject per presentation
- Maximum size is 120MB
- All digital videos must be recorded in English and have some sound; music is not required
- The opening frames of the video presentation must begin with the exact title and include the authors’ names
- Submissions of exceedingly commercial presentations are discouraged, and such submissions are less likely to be accepted for presentation.
- Submissions funded by commercial companies must be identified in a disclaimer at the start of the presentation.
- Digital video presentations that are longer than 8 minutes will automatically be rejected.
Allowed video types: .mov, .mp4
IFRUE Contact Information
All Abstract questions should be directed to Josie Mendez at [email protected]
IFRUE is not responsible for the content of each presentation, which does not represent IFRUE’s opinions.
Abstract Guidelines
Abstract Submission
- All submissions must be made via the IFRUE website www.ifrue.org by July 1, 2025
- The IFRUE Scientific Committee will decide on the presentation category for presentation abstracts.
- Abstract Presentation
- E-Poster
- All accepted abstracts will be published on the IFRUE website exactly as submitted.
- Podium Presentations will be published in an open-access journal or digital media.
- Unpublished abstracts previously presented at other meetings may be considered.
- Anonymity for most objective reviews
- The abstract text must be anonymous. i.e., without any authors’ or institutions’ names. Do not include the name of the hospital, university or city.
- All abstract identification details, references, ethical approval, and disclosures will be taken separately during the online submission process and merged with the abstract text after review.
- Disclosures and funding
- Any external funding of the study or grants must be declared or stated as NONE.
- Abstract Formatting and Subtitles
- The format requested must be at least 300 words but not more than 600 words.
- Do not use characters or symbols from any font set other than Arial.
- Images, figures, graphs and tables can be uploaded with a maximum total of 2 per abstract.
- Abstracts must use the sections given:
- Hypothesis/aims of study
- Study design, materials, and methods
- Results
- Interpretation of results
- Concluding message
- Missing sections will cause rejection.
- Abstract Content.
- Studies must not be split into multiple abstracts. This could lead to each abstract being downgraded.
- Preliminary Data will be considered.
- Abstracts must specify either:
- Pure and Applied Science / Translational
- Clinical
- Abstracts must specify one Broad Category as detailed below:
Categories
Male Lower Urinary Tract Symptoms (LUTS) / Voiding Dysfunction / BPH
Sexual Dysfunction
Female Lower Urinary Tract Symptoms (LUTS) / Voiding Dysfunction / UTI
Female Stress Urinary Incontinence (SUI), Pelvic Organ Prolapse
Male Stress Urinary Incontinence (Post Prostatectomy Incontinence)
Overactive Bladder
Neurourology
Lower Urinary Tract Stricture/Fistula
Upper Urinary Tract Stricture